T1	disease_or_phenotypic_feature 53 62	neoplasms
T2	chemical 84 92	hormones
T3	disease_or_phenotypic_feature 117 134	Metabolic disease
T4	chemical 136 161	potassium channel blocker
T5	disease_or_phenotypic_feature 171 178	obesity
T6	disease_or_phenotypic_feature 195 204	dependent
T7	chemical 254 279	antisense oligonucleotide
T8	chemical 280 289	inhibitor
T9	disease_or_phenotypic_feature 329 337	vaccinia
T10	chemical 354 361	antigen
T11	chemical 458 465	antigen
T12	disease_or_phenotypic_feature 477 483	cancer
T13	chemical 500 507	biology
T16	chemical 615 623	abacavir
T17	chemical 628 638	lamivudine
T18	disease_or_phenotypic_feature 644 653	diarrhoea
T19	disease_or_phenotypic_feature 663 671	vomiting
T20	disease_or_phenotypic_feature 673 687	abdominal pain
T21	chemical 689 693	drug
T22	disease_or_phenotypic_feature 694 710	hypersensitivity
T23	disease_or_phenotypic_feature 715 724	skin rash
T24	chemical 746 755	tamoxifen
T25	disease_or_phenotypic_feature 766 779	breast cancer
T26	chemical 811 819	estrogen
T27	chemical 874 881	antigen
T28	disease_or_phenotypic_feature 903 925	membranous nephropathy
T29	chemical 969 981	desmopressin
T30	chemical 983 994	L-thyroxine
T31	chemical 996 1004	estrogen
T32	disease_or_phenotypic_feature 1048 1066	diabetes insipidus
T33	disease_or_phenotypic_feature 1068 1092	secondary hypothyroidism
T34	disease_or_phenotypic_feature 1097 1126	hypogonadotropic hypogonadism
T35	disease_or_phenotypic_feature 1149 1155	cancer
T36	chemical 1173 1177	drug
T37	chemical 1190 1202	Fenfluramine
T38	chemical 1225 1236	amphetamine
T39	disease_or_phenotypic_feature 1287 1294	obesity
T40	chemical 1300 1307	enzymes
T41	chemical 1311 1317	oxygen
T42	disease_or_phenotypic_feature 1372 1378	cancer
T43	disease_or_phenotypic_feature 1462 1475	hyperglycemia
T44	disease_or_phenotypic_feature 1486 1493	obesity
T45	disease_or_phenotypic_feature 1510 1516	anemia
T46	chemical 1518 1525	mineral
T47	chemical 1546 1563	Pancreatic lipase
T48	chemical 1564 1574	inhibitors
T49	disease_or_phenotypic_feature 1617 1624	obesity
T50	chemical 1626 1633	Alcohol
T51	disease_or_phenotypic_feature 1647 1654	obesity
T52	chemical 1656 1664	estrogen
T53	disease_or_phenotypic_feature 1679 1692	breast cancer
T54	chemical 1695 1702	Calcium
T55	chemical 1703 1714	antagonists
T56	disease_or_phenotypic_feature 1735 1748	heart failure
T57	chemical 1750 1762	Nitric oxide
T58	chemical 1773 1780	biology
T59	disease_or_phenotypic_feature 1785 1791	cancer
T60	disease_or_phenotypic_feature 1804 1813	cataracts
T61	chemical 1836 1842	oxygen
T62	chemical 1940 1947	biology
T63	disease_or_phenotypic_feature 1951 1957	cancer
T64	chemical 2067 2075	antigens
T65	chemical 2184 2192	antigens
T66	disease_or_phenotypic_feature 2205 2216	lung cancer
R1	treats Arg1:T4 Arg2:T5	
T67	corrected_chemical 228 241;254 297	high-affinity antisense oligonucleotide inhibitor of KRAS
T68	missed_chemical 217 224	AZD4785
T69	corrected_disease_or_phenotypic_feature 190 211	KRAS-dependent tumors
R2	treats Arg1:T68 Arg2:T69	
R3	treats Arg1:T67 Arg2:T69	
T70	missed_disease_or_phenotypic_feature 655 661	nausea
T71	corrected_disease_or_phenotypic_feature 689 710	drug hypersensitivity
T15	chemical 568 581	fosamprenavir
T72	corrected_chemical 568 638	fosamprenavir, with or without ritonavir, plus abacavir and lamivudine
R4	causes_or_contributes_to Arg1:T72 Arg2:T18	
R5	causes_or_contributes_to Arg1:T72 Arg2:T70	
R6	causes_or_contributes_to Arg1:T72 Arg2:T19	
R7	causes_or_contributes_to Arg1:T72 Arg2:T20	
R8	causes_or_contributes_to Arg1:T72 Arg2:T71	
R9	causes_or_contributes_to Arg1:T72 Arg2:T23	
R10	treats Arg1:T24 Arg2:T25	
R11	treats Arg1:T30 Arg2:T33	
R12	treats Arg1:T29 Arg2:T32	
R13	treats Arg1:T31 Arg2:T34	
T14	missed_chemical 1009 1020	progestagen
R14	treats Arg1:T14 Arg2:T34	
T73	missed_chemical 1204 1206	FE
T74	corrected_chemical 1213 1247	halogenated amphetamine derivative
R15	treats Arg1:T37 Arg2:T39	
R16	treats Arg1:T73 Arg2:T39	
R17	treats Arg1:T74 Arg2:T39	
T75	corrected_chemical 1296 1307	TET enzymes
R18	treats Arg1:T75 Arg2:T42	
T76	corrected_chemical 1311 1345	oxygen-dependent tumor suppressors
R19	treats Arg1:T76 Arg2:T42	
T77	corrected_chemical 1546 1574	Pancreatic lipase inhibitors
R20	treats Arg1:T77 Arg2:T49	
T78	corrected_chemical 1695 1714	Calcium antagonists
R21	treats Arg1:T78 Arg2:T56	
R22	treats Arg1:T57 Arg2:T59	
T79	corrected_chemical 1825 1842	hyperbaric oxygen
R23	causes_or_contributes_to Arg1:T79 Arg2:T60	
